독감 백신은 있는데, 왜 감기 예방주사는 없을까?｜취미는 과학｜알고e즘

Summary

The video explains why influenza vaccines exist but there is no single vaccine for the common cold. A cold is a syndrome caused by many different viruses, including rhinoviruses and seasonal coronaviruses, whereas influenza is caused by influenza viruses. Because cold-causing viruses are so diverse, developing a vaccine that protects against all colds would be difficult.

Influenza vaccines can be formulated for expected seasonal strains, although the virus may change while the vaccines are being made.

Scientific concepts and phenomena

Cold and influenza are different illnesses

• A cold usually affects the upper respiratory tract and commonly causes a runny or blocked nose and a sore throat.
• Influenza can begin with respiratory symptoms but may spread to the lungs and cause pneumonia. It is often associated with more intense body aches, headache, and sudden onset.
• Rhinoviruses are usually associated with upper-airway illness, but can sometimes cause serious lower-respiratory disease.

How influenza vaccine strains are selected

The World Health Organization (WHO) gathers influenza viruses through laboratories in different countries and analyzes their antigens and genes. It uses this information to forecast likely seasonal strains and announce vaccine strains for the Northern Hemisphere.

Vaccine production takes about six months. During that time, circulating viruses can change, so the strains in a vaccine may not perfectly match the viruses that later spread.

How viruses enter and infect cells

Viruses can attach to receptors on cells in the respiratory tract, much like a key fitting a lock. The subtitles identify sialic-acid receptors for influenza and ACE2 for COVID-19. Once inside a suitable host cell, a virus uses the cell to reproduce, often damaging or destroying it.

Why people can catch colds repeatedly

Rhinoviruses have many different serotypes; the discussion cites more than 170. Many RNA viruses copy their genetic material with limited error correction, which leads to mutations. Some changes help viruses evade existing immunity or bind to cells, while less successful variants tend to disappear.

Are viruses alive?

The video presents competing views. Viruses are inactive outside host cells and lack the cellular structure of living organisms, but inside a host they can reproduce and direct cellular activity.

The discussion also notes that viral shells can be useful as nanostructures, including as potential drug-delivery vehicles.

Viral origins and evolution

Possible origins discussed include viruses emerging from genetic material within early cells, or viruses playing a role in early stages of cellular evolution. The speakers note that some human genes are derived from ancient viruses. They cite research linking an ancient viral gene to processes involved in mammalian reproduction and the evolution of live birth.

Survival outside the body and persistent infections

The speakers give examples of viruses surviving outside the body for different lengths of time, depending on conditions. They say some cold viruses lose activity relatively quickly, while coronaviruses may persist longer in cool conditions.

Norovirus is described as especially persistent and as requiring thorough handwashing with soap and running water. Some viral infections are acute and resolve, while others—such as HIV or the virus that causes shingles—can persist in the body or reactivate later.

Immune response and symptoms

The body’s defenses include physical barriers, innate immune cells, antibodies, and T cells. Fever and symptoms such as a runny nose are described as part of the immune response. An excessive inflammatory response, including a cytokine storm, can instead cause severe tissue damage.

People with weakened immune systems may show fewer early signs while still developing serious illness.

Treatment and prevention

• The speakers recommend rest for a common cold. Cold medicines may ease symptoms but do not directly eliminate the virus.
• Garlic is discussed as food that may provide energy or nutrition, not as a proven cold-specific treatment.
• The influenza vaccine is presented as protecting the vaccinated person and helping reduce spread to vulnerable people, including older adults and young children.

AI-assisted virus design

The video describes a 2025 Stanford research report involving AI-designed bacteriophages that infect E. coli. The work is presented as evidence that AI can help design viral genetic material, alongside a warning that such capabilities require careful oversight.

Researchers and sources featured

• Professor Kim Woo-joo — infectious-disease and influenza expert; associated in the discussion with establishing Korea’s influenza surveillance system.
• Professor Kim Eung-bin — microbiologist, as identified in the video context.
• Professor Jang Hong-je — chemist, as identified in the video context.
• Professor Kang — mentioned in the subtitles, but not identified more fully.
• An unnamed professor at Ewha Womans University — referenced during the discussion of viral origins.
• World Health Organization (WHO) and national influenza laboratories — cited as sources for influenza monitoring and vaccine-strain selection.
• Stanford researchers — cited for the 2025 AI-assisted bacteriophage work.
• A 2016 journal paper — referenced in connection with viral genes and mammalian evolution; the journal and authors are not identified in the subtitles.